Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | April 17, 2023 01:31pm

Gainers

  • ContraFect (NASDAQ:CFRX) stock rose 317.8% to $3.76 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 93.7 million shares, making up 12124.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.8 million.
  • Windtree Therapeutics (NASDAQ:WINT) shares rose 168.54% to $11.76. Trading volume for this security as of 13:30 EST is 9.3 million, which is 6427.0% of its average full-day volume over the last 100 days. The company's market cap stands at $10.6 million.
  • Bellicum Pharmaceuticals (NASDAQ:BLCM) stock increased by 113.44% to $0.6. Bellicum Pharmaceuticals's stock is trading at a volume of 43.9 million shares as of 13:30 EST. This is 42089.8% of its average full-day volume over the last 100 days. The company's market cap stands at $5.4 million.
  • Prometheus Biosciences (NASDAQ:RXDX) stock rose 69.33% to $193.06. As of 13:30 EST, this security is trading at a volume of 11.6 million shares, making up 2436.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.1 billion.
  • Satsuma Pharma (NASDAQ:STSA) stock increased by 66.41% to $1.09. Trading volume for Satsuma Pharma's stock is 40.8 million as of 13:30 EST. This is 26316.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $36.1 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 33.33% to $3.6. Reshape Lifesciences's stock is trading at a volume of 2.0 million shares as of 13:30 EST. This is 286.1% of its average full-day volume over the last 100 days. The company's market cap stands at $6.4 million.

Losers

  • Pear Therapeutics (NASDAQ:PEAR) shares fell 29.0% to $0.05 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 36.5 million shares, making up 518.1% of its average full-day volume over the last 100 days. The company's market cap stands at $7.2 million.
  • Predictive Oncology (NASDAQ:POAI) shares declined by 24.51% to $0.29. As of 13:30 EST, Predictive Oncology's stock is trading at a volume of 5.0 million, which is 363.2% of its average full-day volume over the last 100 days. The company's market cap stands at $22.7 million.
  • Allarity Therapeutics (NASDAQ:ALLR) shares declined by 18.75% to $1.17. The current volume of 2.3 million shares is 461.2% of Allarity Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $1.1 million.
  • BIMI Intl Medical (NASDAQ:BIMI) stock fell 18.24% to $0.59. Trading volume for this security as of 13:30 EST is 255.9K, which is 370.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.2 million.
  • Bionano Genomics (NASDAQ:BNGO) stock declined by 16.37% to $0.91. As of 13:30 EST, Bionano Genomics's stock is trading at a volume of 22.0 million, which is 365.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $279.1 million.
  • Creative Medical Tech (NASDAQ:CELZ) shares decreased by 13.92% to $0.61. As of 13:30 EST, this security is trading at a volume of 813.6K shares, making up 20.2% of its average full-day volume over the last 100 days. The company's market cap stands at $8.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLR BIMI BLCM BNGO CELZ CFRX PEAR POAI RSLS RXDX STSA WINT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist